HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

monoclonal antibody BIWA 4 (bivatuzumab)

humanized monoclonal antibody with an intermediate affinity for CD44v6 for treatment of squamous cell carcinoma of head & neck
Also Known As:
bivatuzumab; BIWA 4 (MAb)
Networked: 5 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Roos, Jan C: 3 articles (10/2003 - 09/2003)
2. de Bree, Remco: 3 articles (10/2003 - 09/2003)
3. van Dongen, Guus A M S: 3 articles (10/2003 - 09/2003)
4. Hanft, Gertraud: 2 articles (09/2008 - 09/2003)
5. Heider, Karl-Heinz: 2 articles (12/2004 - 09/2003)
6. Börjesson, Pontus K E: 2 articles (10/2003 - 09/2003)
7. Marres, Henri A M: 2 articles (10/2003 - 09/2003)
8. Oyen, Wim J G: 2 articles (10/2003 - 09/2003)
9. Postema, Ernst J: 2 articles (10/2003 - 09/2003)
10. Colnot, David R: 2 articles (09/2003 - 09/2003)

Related Diseases

1. Squamous Cell Carcinoma of Head and Neck
2. Head and Neck Neoplasms (Head and Neck Cancer)
3. Neoplasms (Cancer)
4. Residual Neoplasm
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. monoclonal antibody BIWA 4 (bivatuzumab)
2. Monoclonal Antibodies
3. Maytansine (Maitansine)

Related Therapies and Procedures

1. Therapeutics
2. Radioimmunotherapy